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INTRODUCTION
Cancer is a major public health problem in both developed 
and developing countries. It was estimated that there were 
10.9 million new cases, 6.7 million deaths, and 24.6 million 
persons living with cancer around the world in 2002.[1,2] In 
the US, cancer is the second leading cause of  death,[3] where 
one in four deaths is due to cancer.[2] Since 1990, there has 
been a 22% increase in cancer incidence and mortality with 
the four most frequent cancers being lung, breast, colorectal, 
and stomach.[4,5] Medicinal plants have played important roles 
in the last fi ve decades in the treatment of  cancer and most 
new clinical applications of  plant secondary metabolites and 
their derivatives have been applied towards combating cancer. 
Ageratum conyzoides L. belongs to the family and tribe of  
Asteraceae and Eupatoriae, respectively. It is native to Central 
America, Caribbean, Florida (USA), Southeast Asia, South 
China, India, Nigeria, Australia, and South America. [6,7] It is 
traditionally called “ufu opioko” and “otogo” by the Igedes in 
Benue state, Nigeria.[8] In Southwestern Nigeria, it is known as 
“Imí esú”.[9] A. conyzoides has been used in folklore for the 
treatment of  fever, pneumonia, cold, rheumatism, spasm, 
headache, and curing wounds.[10,11] Its gastroprotective,[11] 
antibacterial,[12] anti-infl ammatory, antianalgesic, antipyretic,[6] 
anticoccidial,[13] and anticonvulsant[14] properties have been 
reported. However, to the best of  our knowledge, the in vitro 
anticancer activity of  this plant has never been evaluated 
and published. Natural products from plants can be another 
potent source for the discovery of  anticancer and antioxidant 
agents. In this article, we describe the in vitro anticancer 
activity of  ethanol, petroleum ether, ethylacetate, butanol, 
and water extracts of  A. conyzoides against some cancer cell 
lines: Human non-small cell lung (A-549), human gastric 
(SGC-7901), human colon (HT-29), human golima (U-251), 
human breast carcinoma (MDA-MB-231), human prostate 
carcinoma (DU-145), human hepatic carcinoma (BEL-7402), 
and mouse leukemia (P-388) cancer cell lines as well as the 
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Ageratum conyzoides has been used in folklore for the treatment of a wide range of diseases. In the present investigation, 
the in vitro activity of ethanol, petroleum ether, ethylacetate, butanol, and water extracts of A. conyzoides were screened 
in some cancer cell lines using the sulphorhodamine B (SRB) assay. These cell lines include: Human non-small cell lung 
carcinoma (A-549), human colon adenocarcinoma (HT-29), human gastric carcinoma (SGC-7901), human golima (U-251), 
human breast carcinoma (MDA-MB-231), human prostate carcinoma (DU-145), human hepatic carcinoma (BEL-7402), and 
mouse leukemia (P-388) cancer cell lines. Furthermore, kaempferol was isolated from the ethylacetate extract and the structure 
was elucidated by nuclear magnetic resonance (NMR) and mass spectroscopy. The effect of DPPH antiradical activity on the 
extracts and kaempferol was also determined. The results showed that ethylacetate extract exhibited the highest cytotoxic 
activity on A-549 and P-388 cancer cells with IC50 values of 0.68 and 0.0003 g/ml, respectively. Kaempferol isolated 
from the ethylacetate extract of A. conyzoides rapidly scavenged DPPH at a concentration of 130.07 ± 17.36 g/ kg. The 
result therefore showed that A. conyzoides possessed anticancer and antiradical properties.
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the campus of  Covenant University, Ota, Ogun State, 
Nigeria, in December, 2007. The plant was authenticated at 
the Department of  Pharmacognosy, University of  Lagos, 
Lagos, Nigeria and a voucher specimen (PCGH 436) was 
deposited in the Herbarium for reference purpose.
Reagents and cancer cell lines
All extraction reagents used such as ethanol, petroleum 
ether, ethylacetate, and n- butanol were of  analytical reagent 
grade. Trypsin, trizima base, sulforhodamine B (SRB), 
trichloroacetic acid, RPMI-1640 culture medium, and 
trypan blue solutions were purchased from Sigma Chemicals 
Co., Ltd. (St. Louis, MO, USA). 1,1-diphenyl -2- picryl 
hydrazyl (DPPH) free radical reagent was bought from 
Tokyo Chemical Industry company (TCI), Japan. The purity 
of  methanol reagent used from Yuwang Group, Shandong, 
China was 99.9%. Human non-small cell lung carcinoma 
(A-549), human colon adenocarcinoma (HT-29), human 
gastric carcinoma (SGC-7901), human golima (U-251), 
human breast carcinoma (MDA-MB-231), human prostate 
carcinoma (DU-145), human hepatic carcinoma (BEL- 7402), 
and mouse leukemia (P-388) cancer cell lines were obtained 
from Shanghai Institute of  Materia Medica, Chinese 
Academy of  Sciences (Shanghai, China) and the Cell Culture 
Centre of  Institute of  Basic Medical Sciences, Chinese 
Academy of  Medical Sciences (Peking, China).
Extraction and fractionation of the plant
The procedure described by[15] was adopted. The leaves 
of  A. conyzoides were collected and air-dried in the 
laboratory for two weeks after which they were blended 
into fi ne powder. One hundred grams were extracted with 
95% ethanol. Evaporation of  the extract in a rotatory 
evaporator (Buchi 461, Switzerland) at 40C yielded an 
ethanol extract (32 g). The residue (14 g) was dissolved 
in deionized water (100 mL) and successively extracted 
with petroleum ether (0.5 L  4), ethylacetate (0.5L  5), 
and n- butanol (0.5 L  5) solvents. The petroleum ether, 
ethylacetate, n-butanol, and water fractions yielded 1.1, 0.5, 
1.1, and 1.6 g, respectively. Each fraction was evaporated 
under reduced pressure and subsequently screened for 
anticancer and antiradical activities.
Purifi cation, isolation, and structure elucidation of 
compound
The ethylacetate extract (173 g) was fractionated by column 
chromatography (CC) (1.4 kg silica gel, mesh 100-200; 
CHCl3: MeOH 9:1, 7:3, 1:1, 3:7 and 1:4). Fractions 3 and 
4 were respectively separated by CC (1. sephadex LH-20 
CHCl3: MeOH 2:1; 2. Pet. ether: Acetone 2:1,) and afforded 
kaempferol (5.0 mg). 3,5,7,4'-tetrahydroxyfl avone, kaempferol, 
yellow powder, C15H10O6,
1H-NMR (400 MHz, CD3OD), 
H: 6.17 (1H, d, J   1.4 Hz, H-6), 6.38 (1H, s, H-8), 8.07 
(1H, d, J  8.7 Hz, H-2), 6.89 (1H, d, J  8.7 Hz, H-3 ), 
6.89 (1H, d, J   8.7 Hz, H-5 ), 8.07(1H, d, J  8.7 Hz, 
H-6).13C-NMR (100 MHz, CD3OD), c: 148.0(s, C-2), 
137.1(s, C-3), 177.4 (s, C-4), 104.5 (s, C-4a), 162.5 (s, C-5), 
99.2 (d, C-6), 165.6 (s, C-7), 94.4 (d, C-8), 160.5 (s, C-8a), 
123.7 (s, C-1), 130.7 (d, C-2), 116.3 (d, C-3), 158.2 (s, C-4), 
116.2 (d, C-5), 130.7 (d, C-6). EI-MS m/z (%): 286 [M] 
(100), 285 (35), 258 (14), 229 (14), 213 (12), 121 (43), 69 (21). 
EI-MS was recorded on a VG Auto Spec-3000 spectrometer 
(Britain). Proton Nuclear Magnetic Resonance (1H-NMR) 
and Carbon-13 (13C)-NMR spectra were recorded on 
Bruker AM-400 and DRX-500 spectrometers (Rheinstteten, 
Germany) with tetramethylsilane (TMS) as internal standard. 
Column chromatography was carried out over silica gel 
(200-300 mesh, Qingdao Marine Chemical Inc., China) and 
sephadex LH-20 (25-100 m, Pharmacia Fine Chemical Co., 
Ltd., Sweden), respectively.
Cancer cell growth inhibition assay
The procedures described by[16,17] were followed. Briefl y, the 
sulphorhodamine B (SRB) assay was adopted for a quant 
measurement of  cell growth and viability. Cells were seeded 
in 96-well microtiter plates at 3000-7000 cells per well. 
After 24 hour, extracts were added to a fi nal concentration 
of  10 g/ml and incubated for 48 hour. Cells were then 
fi xed by the addition of  50% ice-cold Cl3CCOOH and 
then left at 4oC for 1 hour. After washing, air-drying 
and staining was done for 15 minutes with 100 l 0.4% 
SRB in 1% glacial AcOH; excessive dye was removed by 
washing with 1% glacial AcOH. The absorbance values of  
resuspended SRB in 10 mM Tris buffer was read at 560 nm 
on a microplate spectrophotometer (SPECTRA MAX 340, 
USA); further assessment was carried out with at least 
four serially diluted concentrations (dilution ratio 1:2) with 
sample inhibition of  50% or more to obtain the IC50 value. 
The IC50 value was calculated from the following formular:
log (IC )=




10 L H 10 H L
H L
50 10 (IC )50
Where:
IH: I% above 50%
IL: I% below 50%
CH: High drug concentration
CL: Low drug concentration
DPPH antiradical assay
The effects of  1,1-diphenyl-2-picrylhydrazyl (DPPH) 
antiradical or antioxidant potentials of  the extracts were 
determined according to the procedures described by[18] 
with slight modifi cations. Aliquots of  5 L of  dimethyl 
sulphoxide (DMSO) solutions each containing extract of  
four replicates were added to 195 L of  pure methanol 
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solution of  DPPH (0.025 g/L). Absorbance at 515 nm 
against a blank of  methanol without DPPH was determined 
after 30 minutes of  incubation at room temperature in a 
microplate spectrophotometer (SPECTRA MAX 340, USA). 
Six serially diluted concentrations of  samples with initial % 
activity of  50 or more were prepared and using the above 
procedure, absorbance of  each sample concentration against 
a methanol blank was read. A graph of  % activity against 
concentration was plotted for each sample. The EC50 value, 
which is the amount of  antioxidant necessary to decrease 
the initial DPPH concentration by 50%, was determined.
RESULTS
Characterization of compound
The compound [Figure 1] obtained was yellow and 
its molecular weight as determined by Fast Atom 
Bombardment Mass Spectroscopy (FAB-MS) was 286. 
From the 1H-NMR, 13C-NMR, and Distortionless 
Enhancement by Polarization Transfer (DEPT) spectra, the 
molecular formula, C15H10O6 was derived. From the spectra 
data, it was found that the structure of  the compound 
belongs to fl avonoid group and when the structure was 
compared with established literature data, it was identifi ed 
as 3,5,7,4'-tetrahydroxyfl avone (kaempferol).[19,20]
DPPH antiradical activity
The preliminary result of  the effect of  extracts of  
A. conyzoides on the DPPH scavenging activity showed that 
the water extract, n-butanol extract, and ethylacetate extract 
have % activity of  87.80, 85.40, 72.56, and 60.87, respectively, 
while the petroleum ether extract had a % activity of  7.84 
[Table 1]. EC50 value is the effective concentration required 
to scavenge 50% of  the DPPH radical and was extrapolated 
from a linear graph. Kaempferol showed an EC50 value 
of  130.07 ± 17.36 g/ kg and was highly comparable to 
the standard control (vitamin C) with an EC50 value of  
127.13 ± 8.56 g/kg [Figure 2].
Anticancer activity
From the preliminary anticancer screening, the petroleum 
ether extract of  A. conyzoides exhibited a signifi cant inhibition 
(I  50%) on SGC-7901, HT-29, and P-388 cancer cell lines 
[Tables 2 and 3]. Similarly, the ethylacetate extract showed a 
signifi cant inhibition on A-549, SGC-7901, HT-29, P-388, 
MDA-MB-231, and DU-145 cancer cell lines. Furthermore, 
ethanol extract had a signifi cant inhibitory activity on 
HT-29 and P-388 cancer cell lines. n-Butanol and water 
extracts showed no signifi cant inhibition (I  50%) on 
any of  the cancer cell lines. Table 4 shows the IC50 values 
of  ethanol, petroleum ether, and ethylacetate extracts. The 
ethanol extract showed an IC50 value of  1.73 g/ml in 
P-388 cell line, while petroleum ether extract had IC50 values 
of  14.06, 13.77, and 0.71 g/ ml in A-549, SGC-7901, and 
P-388 cells, respectively. Similarly, the ethylacetate extract 
showed IC50 values of  0.68, 9.97, 14.88, and 0.0003 g/ml 
in A-549, DU-145, SGC-7901, and P-388 cells, respectively.
DISCUSSION AND CONCLUSION
Cancer is one of  the most widespread diseases in humans 
and there is considerable scientifi c and commercial interest 
in the continuing discovery of  new anticancer agents from 
Figure 1: Structure of kaempferol
Figure 2: DPPH scavenging activity of extracts and compounds from 
Ageratum conyzoides
Table 1: Preliminary investigation of DPPH 
scavenging activity of the leaf extracts of 
Ageratum conyzoides
Extracts DPPH assay (mg/mL) Activity (%)










Ascorbic acid (vit C) 0.01 
 0.001 96.87*
Tabulated values are mean 
 standard deviation of three replicates. *I %  50 of 
samples which were re-evaluated to determine their EC50 values
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natural product sources.[21,22] Currently, over 50% of  drugs 
used in clinical trials for anticancer activity were isolated 
from natural sources or are related to them.[23] A number of  
active compounds have been shown to possess anticancer 
activity; these include fl avonoids, diterpenoids, triterpenoids, 
and alkaloids.[17] Several mechanisms have been proposed to 
explain the cancer-preventive effects of  plants. These include 
inhibition of  mutagenesis by inhibiting the metabolism, 
inhibition of  DNA adduct formation, free-radical scavenging, 
and effects on cell proliferation and tumor growth.[24] In the 
present study, the petroleum ether and ethylacetate extracts 
of  ethanolic extract of  A. conyzoides showed inhibitory activity 
on a wide range of  cancer cell lines with ethylacetate extract 
having the greatest activity. It could therefore be deduced that 
the ethylacetate and petroleum ether extracts of  A. conyzoides 
possess anticancer properties. Flavonoids have been 
implicated as responsible for the anticancer activities of  some 
medicinal plants. The study of[17] showed that the fl avonoids 
cis-2,5,7-trihydroxyfl avanonol-3-O-	-D-glucopyranoside and 
chrysin-6-C-	-D-glucopyranosyl-8-C--L-arabinopyranoside 
exhibited significant cytotoxicity activity on A-549 and 
BGC- 823 cancer cell lines. Thus, fl avonoids may be responsible 
for the anticancer activity of  A. conyzoides. Studies conducted 
by[25,26] reported a high correlation between DPPH radical 
scavenging potential and total phenolic content. Kaempferol 
(3,5,7,4'-tetrahydroxyfl avone) is one of  the most commonly 
found dietary fl avonols. Kaempferol has also been found to be 
a blocker of  reactive oxygen species (ROS) production by low 
K-induced apoptosis in cerebella granule cells. [27] According 
to previous reports, antioxidant activity of  kaempferol was 
believed to have cytoprotective function against oxidative 
stress. It seemed to suggest that kaempferol may not only 
Table 2: Treatment of the leaf extracts of Ageratum conyzoides with human non-small cell lung cancer 
cell line (A 549), human gastric cancer cell line (SGC 7901), human colon cancer cell line (HT-29), and 
human golima cancer cell line (U-251)
Extracts A 549 (mg/mL) SGC 7901 (mg/mL) HT 29 (mg/mL) U-251 (mg/mL)
Control 1.60 
 0.08 1.60 
 0.08 0.85 
 0.12 0.45 
 0.05
Petroleum ether 0.44 
 0.02 (39.42) 0.77 
 0.02 (52.02)* 0.60 
 0.05 (53.30)* 0.52 
 0.02 (17.55)
Ethylacetate 0.25 
 0.02 (66.01)* 0.57 
 0.02 (64.37)* 0.29 
 0.04 (66.24)* 0.43 
 0.03 (2.73)
n-Butanol 0.99 
 0.05 (35.09) 1.61 
 0.01 (3.44) 0.87 
 0.02 (0.22) 0.64 
 0.02 (42.85)
Water 0.90 
 0.06 (23.66) 1.68 
 0.04 (5.09) 1.19 
 0.09 (7.93) 0.65 
 0.02 (46.45)
Ethanol 0.56 
 0.05 (23.94) 0.86 
 0.02 (26.71) 0.37 
 0.02 (60.27)* 0.44 
 0.06 (13.65)
Tabulated values are Mean 
 Standard deviation of three replicates. Values in parenthesis indicate percentage inhibition (I %), *I %  50 of samples which were further 
evaluated to determine their IC50
Table 3: Treatment of the leaf extracts of Ageratum conyzoides with human breast carcinoma cell line 
(MDA-MB-231), human prostate carcinoma cell line (DU-145), human hepatic carcinoma cell line
(BEL-7402), and mouse leukemia cell line (P - 388)









 0.16 0.38 
 0.02 0.48 
 0.06 0.74 
 0.08
Petroleum ether 0.50 
 0.10 (34.376) 0.26 
 0.01 (31.26)  0.39 
 0.01 (19.86) 0.031 
 0.003 (95.88)*
Ethylacetate 0.25 
 0.01 (67.57)* 0.07 
 0.01 (81.06)*  0.27 
 0.02 (44.01) 0.04 
 0.003 (94.62)*
n-Butanol 0.70 
 0.01 (8.70) 0.38 
 0.02 (0.26)  0.47 
 0.03 (3.13) 0.29 
 0.06 (23.01)
Water 0.84 
 0.15 (9.53) 0.41 
 0.01 (6.53)  0.52 
 0.01 (6.30) 0.78 
 0.10 (4.75)
Ethanol 0.54 
 0.13 (29.52) 0.34 
 0.01 (11.41)  0.45 
 0.01 (6.30) 0.171 
 0.03 (76.93)*
Tabulated values are Mean 
 Standard deviation of three replicates. Values in parenthesis indicate percentage inhibition (I %), *I %  50 of samples which were further 
evaluated to determine their IC50















A-549 - 14.06 0.68 - - 0.02 0.031
DU-145 -  - 9.90  -  - 0.04 -
MDA-MB-231 - - - - - - 3.14
BEL-7402 - - - - - 0.58 -
SGC-7901 - 13.77 14.38 - - 0.003 -
HT-29 - - - - - 0.004 -
P-388 1.73 0.71 0.0003 - - 0.00008 -
U-251 - - - - - 0.005 -
Taxol and hydroxy-camptothecin (HCPT) are positive control drugs
66 Pharmacognosy Magazine | January 2010 | Vol 6 | Issue 21
Adebayo, et al.: Anticancer and antiradical activity of A. conyzoides
protect cells from free radical damage via antioxidant effect, 
but also induce apoptotic cell death, via pro-oxidant activity, 
in malignant cell lines and to inhibit tumorigenesis.[28] The 
antitumor, anti-infl ammatory, antiulcer activity, and HIV 
protease inhibitory activity of  kaempferol have also been 
reported. [20,29] The result of  the present investigation showed 
that A. conyzoides possesses antiradical activity and the property 
resides on the ethyl acetate extract. Kaempferol, which was 
isolated from this extract, was found to scavenge DPPH 
radical. It could therefore be deduced that the bioactive 
compound responsible for the antiradical activity of  A. 
conyzoides is 3,5,7,4'-tetrahydroxyfl avone (kaempferol). Further 
research is needed to unravel the specifi c bioactive compounds 
responsible for the anticancer properties of  the extracts of  A. 
conyzoides. In conclusion, the study has not only established the 
anticancer property of  the extracts of  A. conyzoides but also 
its antioxidant activity. Thus, the plant could be employed in 
ethno-medicine for the management of  cancerous diseases.
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